Heyue Zhou - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Heyue Zhou

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Antiviral Research|October 11, 2021

SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancementYing-Ting Wang, Robert D Allen, Kenneth Kim, et al.

Scientific Reports|September 15, 2022

Unbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodiesXia Cao, Junki Maruyama, Heyue Zhou, et al.

Med (New York, N.Y.)|August 31, 2022

Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariantsJ Andrew Duty, Thomas Kraus, Heyue Zhou, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Antiviral Research|October 11, 2021

SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancementYing-Ting Wang, Robert D Allen, Kenneth Kim, et al.

Scientific Reports|September 15, 2022

Unbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodiesXia Cao, Junki Maruyama, Heyue Zhou, et al.

Med (New York, N.Y.)|August 31, 2022

Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariantsJ Andrew Duty, Thomas Kraus, Heyue Zhou, et al.

Pageof 2